Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.3330
+0.0600 (21.98%)
At close: May 21, 2026, 4:00 PM EDT
0.3338
+0.0008 (0.24%)
Pre-market: May 22, 2026, 5:15 AM EDT
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $40.25 million as of May 21, 2026. Its market cap has decreased by -12.49% in one year.
Market Cap
40.25M
Enterprise Value
59.69M
1-Year Change
-12.49%
Ranking
Category
Stock Price
$0.33
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has decreased from $97.37M to $40.25M, a decrease of -58.66%. That is a compound annual growth rate of -8.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 40.25M | -60.27% |
| Dec 31, 2025 | 101.30M | 115.21% |
| Dec 31, 2024 | 47.07M | -54.10% |
| Dec 29, 2023 | 102.54M | -63.01% |
| Dec 30, 2022 | 277.20M | -9.11% |
| Dec 31, 2021 | 304.99M | 84.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 44.70M |
| Mereo BioPharma Group | 43.43M |
| Atossa Therapeutics | 42.80M |
| Nutriband | 42.42M |
| Lite Strategy | 40.18M |
| RenovoRx | 39.72M |
| INmune Bio | 38.28M |
| Lantern Pharma | 37.21M |